These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31683186)

  • 1. Concurrent Alcohol and Opioid Use Among Harm Reduction Clients.
    Winstanley EL; Stover AN; Feinberg J
    Addict Behav; 2020 Jan; 100():106027. PubMed ID: 31683186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
    Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
    Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder.
    Connery HS; Taghian N; Kim J; Griffin M; Rockett IRH; Weiss RD; Kathryn McHugh R
    Drug Alcohol Depend; 2019 Dec; 205():107612. PubMed ID: 31627077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital admissions among people who inject opioids following syringe services program implementation.
    Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
    Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs.
    Sarasa-Renedo A; Espelt A; Folch C; Vecino C; Majó X; Castellano Y; Casabona J; Brugal MT;
    Gac Sanit; 2014; 28(2):146-54. PubMed ID: 24418018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid overdose prevention in a residential care setting: Naloxone education and distribution.
    Pade P; Fehling P; Collins S; Martin L
    Subst Abus; 2017; 38(1):113-117. PubMed ID: 27093647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process evaluation of the Prevent Overdose in Toronto (POINT) program.
    Leece P; Gassanov M; Hopkins S; Marshall C; Millson P; Shahin R
    Can J Public Health; 2016 Oct; 107(3):e224-e230. PubMed ID: 27763835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
    Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential risks of syringe service program participants in Central Ohio: a latent class analysis.
    Moon KJ; Bryant I; Trinh A; Hasenstab KA; Carter B; Barclay R; Nawaz S
    Harm Reduct J; 2023 Jul; 20(1):97. PubMed ID: 37507721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017.
    Tori ME; Larochelle MR; Naimi TS
    JAMA Netw Open; 2020 Apr; 3(4):e202361. PubMed ID: 32271389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention.
    Gicquelais RE; Genberg BL; Maksut JL; Bohnert ASB; Fernandez AC
    Harm Reduct J; 2022 Dec; 19(1):135. PubMed ID: 36463189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
    Roxburgh A; Hall WD; Gisev N; Degenhardt L
    Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
    Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
    Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndemic factors associated with non-fatal overdose among young opioid users in New York City.
    Guarino H; Frank D; Quinn K; Kim D; Gile K; Ruggles K; Friedman SR; Mateu-Gelabert P
    Front Public Health; 2023; 11():1195657. PubMed ID: 37435512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.